-Stay consistent with check-ins and follow-ups
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
Studies have shown that individuals carrying the Arg48His variant have a more than threefold increased risk of lung cancer when drinking 10 to 29.9 g of alcohol daily [135]
Vitamin B12 is important for proper digestion, and a deficiency can lead to digestive issues such as diarrhoea, constipation, and loss of appetite